GNAS-Related Loss-of-Function Disorders and the Role of Imprinting

被引:41
作者
Linglart, Agnes [1 ,2 ,3 ]
Maupetit-Mehouas, Stephanie [4 ]
Silve, Caroline [1 ,2 ,3 ]
机构
[1] French Ctr Reference Rare Disorders Calcium & Pho, Le Kremlin Bicetre, France
[2] INSERM U986, Le Kremlin Bicetre, France
[3] Univ Paris 11, Bicetre Paris Sud Hosp, Le Kremlin Bicetre, France
[4] Clermont Univ, CNRS 6293, INSERM U1103, Clermont Ferrand, France
来源
HORMONE RESEARCH IN PAEDIATRICS | 2013年 / 79卷 / 03期
关键词
Parathyroid hormone; Imprinting; Pseudohypoparathyroidism; GNAS; PSEUDOHYPOPARATHYROIDISM TYPE-IB; ALBRIGHT HEREDITARY OSTEODYSTROPHY; PROGRESSIVE OSSEOUS HETEROPLASIA; IDENTIFIES PDE4D MUTATIONS; HORMONE-RELEASING-HORMONE; GS-ALPHA GENE; AUTOSOMAL-DOMINANT; INACTIVATING MUTATIONS; PARATHYROID EXTRACT; EPIGENETIC DEFECTS;
D O I
10.1159/000348516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GNAS (guanine nucleotide-binding protein, alpha stimulating) is a complex imprinted locus coding, besides the alpha-stimulatory subunit of the G protein, the paternally (extra-large, antisense and A/B) and maternally (neuroendocrine secretory protein) transcripts. Heterozygous mutations in the coding sequence of GNAS produce dominant phenotypes (combination of resistances to hormones signaling through G-protein-coupled receptors, osteodystrophy and obesity) that depend on the parental origin of the mutated allele. Likewise, alterations in the methylation at promoters of GNAS transcripts, associated or not with deletions of imprinting control regions in the nearby STX16 gene or within GNAS, prompt resistance to parathormone when affecting the maternal allele. Therefore, imprinting of GNAS is the determining factor for the variability of the phenotype. Knowledge of the various phenotypes is necessary for genetic counseling as well as an appropriate therapeutic balance between regular follow-up, prevention of disease complications and iatrogeny. Copyright (c) 2013 S. Karger AG, Basel
引用
收藏
页码:119 / 129
页数:11
相关论文
共 65 条
[1]   Resistance to epinephrine and hypersensitivity (hyperresponsiveness) to CB1 antagonists in a patient with pseudohypoparathyroidism type Ic [J].
Al-Salameh, Abdallah ;
Despert, F. ;
Kottler, Marie-Laure ;
Linglart, Agnes ;
Carel, Jean-Claude ;
Lecomte, Pierre .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (04) :819-824
[2]  
Albright F, 1942, ENDOCRINOLOGY, V30, P922
[3]   Hypothyroidism in patients with pseudohypoparathyroidism type Ia: clinical evidence of resistance to TSH and TRH [J].
Balavoine, Anne-Sophie ;
Ladsous, Miriam ;
Velayoudom, Fritz-Line ;
Vlaeminek, Virginie ;
Cardot-Bauters, Catherine ;
d'Herbomez, Michele ;
Wemeau, Jean-Louis .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (04) :431-437
[4]   Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib [J].
Bastepe, M ;
Fröhlich, LF ;
Linglart, A ;
Abu-Zahra, HS ;
Tojo, K ;
Ward, LM ;
Jüppner, H .
NATURE GENETICS, 2005, 37 (01) :25-27
[5]   Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS [J].
Bastepe, M ;
Fröhlich, LF ;
Hendy, GN ;
Indridason, OS ;
Josse, RG ;
Koshiyama, H ;
Körkkö, J ;
Nakamoto, JM ;
Rosenbloom, AL ;
Slyper, AH ;
Sugimoto, T ;
Tsatsoulis, A ;
Crawford, JD ;
Jüppner, H .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) :1255-1263
[6]   Paternal uniparental isodisomy of chromosome 20q -: and the resulting changes in GNAS1 methylation -: as a plausible cause of pseudohypoparathyroidism [J].
Bastepe, M ;
Lane, AH ;
Yüppner, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (05) :1283-1289
[7]  
Bastepe M, 2008, ADV EXP MED BIOL, V626, P27
[8]   METABOLIC BONE-DISEASE IN PSEUDOHYPOPARATHYROIDISM - RADIOLOGIC FEATURES [J].
BURNSTEIN, MI ;
KOTTAMASU, SR ;
PETTIFOR, JM ;
SOCHETT, E ;
ELLIS, BI ;
FRAME, B .
RADIOLOGY, 1985, 155 (02) :351-356
[9]   Resistance to the lipolytic action of epinephrine:: A new feature of protein Gs deficiency [J].
Carel, JC ;
Le Stunff, C ;
Condamine, L ;
Mallet, E ;
Chaussain, JL ;
Adnot, P ;
Garabédian, M ;
Bougnères, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4127-4131
[10]  
Chillambhi S, 2008, DELETION GNAS ANTISE